To our knowledge, the present study is the first meta-analysis to investigate the associations of ABCB1 and ABCG2 polymorphisms with sunitinib-induced toxicity and efficacy in patients with RCC. The gene discussed is ABCG2; the disease is renal cell carcinoma.